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Abstract
Background: Severe mental illness (SMI) is associated with care delivery problems because of the high levels of
clinical resources needed to address patient’s psychosocial impairment and to support inclusion in society. Current
routine appointment systems do not adequately foster recovery care and are not systematically capturing
information suggestive of urgent care needs. This study aimed to assess the feasibility, acceptability, and potential
clinical benefits of a mobile technology health management tool to enhance community care for people with
severe mental illness.
Methods: This randomised-controlled feasibility pilot study utilised mixed quantitative (measure on subjective
quality of life as primary outcome; questionnaires on self-management skills, medication adherence scale as
secondary outcomes) and qualitative (thematic analysis) methodologies. The intervention was a simple interactive
technology (Short Message Service - SMS) communication system called ‘Florence’, and had three components:
medication and appointment reminders, daily individually defined wellbeing scores and optionally coded request
for additional support. Eligible participants (diagnosed with schizophrenia, schizoaffective disorder or bipolar
disorder ≥1 year) were randomised (1:1) to either treatment as usual (TAU, N = 29) or TAU and the technology-
assisted intervention (N = 36).
Results: Preliminary results suggest that the health technology tool appeared to offer a practicable and acceptable
intervention for patients with SMI in managing their condition. Recruitment and retention data indicated feasibility,
the qualitative analysis identified suggestions for further improvement of the intervention. Patients engaged well
and benefited from SMS reminders and from monitoring their individual wellbeing scores; recommendations were
made to further personalise the intervention. The care coordinators did not utilise aspects of the intervention per
protocol due to a variety of organisational barriers. Quantitative analysis of outcomes (including a patient-reported
outcome measure on subjective quality of life, self-efficacy/competence and medication adherence measures) did
not identify significant changes between groups over time in favour of the Florence intervention, given high
baseline scores. The wellbeing scores, however, were positively correlated with all outcome measures.
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Conclusion: It is feasible to conduct an adequately powered full trial to evaluate this intervention. Inclusion criteria
should be revised to include patients with a higher level of need and clinicians should receive more in-depth
assistance in managing the tools effectively. The preliminary data suggests that this intervention can aid recovery
care and individually defined wellbeing scores are highly predictive of a range of recovery outcomes; they could,
therefore, guide the allocation of routine care resources.
Trial registration: ISRCTN34124141; retrospectively registered, date of registration 05/11/2019.
Keywords: Mobile health technology, Recovery care, Self-management, Severe mental illness, RCT
Background
Between 0.5 and 1% of the population experience severe
mental illness (SMI) during their lifetime and about a
third of patients develop a more chronic course of their
illness, in particular those with chronic psychosis
(Schizophrenia, Schizoaffective Disorder, Bipolar Dis-
order) [1]. A high percentage of these patients continue
to have poor outcomes, including social isolation, med-
ical comorbidity, and poor quality of life [2–6].
Due to the complexity of the illness patients often re-
quire help and support from a range of health and social
care professionals, which may result in problems with
the coordination and timely delivery of all the care com-
ponents. Many studies identified that people living with
SMI struggle to comply with their treatment over time,
and a significant number of people disengage from
services [7–9]. A recent systematic review identified a
negative attitude toward medication as a key reason
directly associated with intentional non-adherence.
Negative attitude to medication was also associated with
level of insight and the quality of the therapeutic alliance
[10]. Several of these factors are modifiable, and
therefore, interventions aiming to enhance patient’s self-
management skills, knowledge, and motivation may
help improve overall treatment adherence. Levin et al.
(2016) emphasised that “for adherence-enhancement
approaches to be widely adapted, they need to be eas-
ily accessible, affordable, and practical” [11, p. 819].
System support factors such as shared decision mak-
ing, the impact of side effects, and the way patients
are provided with information about medication and
their potential side effects have been discussed in the
literature as compounding factors for treatment
adherence [e.g. 10, 11].
Current routine appointment systems do not suffi-
ciently provide for immediate care needs in a timely
fashion and patients have little control over their care
arrangements, while the recovery care agenda empha-
sised the importance of empowerment for people with
SMI [12]. In addition, enduring conditions such as SMIs
carry a high economic burden with significant costs to
the NHS; accounting for approximately £2.4–2.8 billion
total annual cost to the English NHS [13]. New and
cost-effective ways of delivering integrated health and
social care for patients with SMI are required. Lean et al.
(2019) conducted a systematic review and meta-analysis
of research on self-management for people with severe
mental illness and found that “there is evidence that the
provision of self-management interventions alongside
standard care improves outcomes for people with SMI”;
they concluded that these interventions “should form
part of the standard package of care provided to people
with SMI and should be prioritised in guidelines: re-
search on best methods of implementing such interven-
tions in routine practice is needed” [14 , p. 260].
Mobile health (“m-health”) technology has been
increasingly proposed and tested as possible clinical
and cost-effective solutions to foster self-management,
monitor signs of relapse via self-report, and to
improve attendance rate for routine appointments and
medication adherence [15–19]. One of these m-health
technologies is the ‘Florence Telehealth’ system; a
recent Kings Fund report (2018) summarised the
adoption and spread of innovation in the NHS and
concluded that ‘Florence’ had the potential to improve
quality of life for patients with long-term conditions
[20]. An adapted version of ‘Florence’ has now been
developed for people with SMI; this intervention uses
a newly developed simple interactive text messaging
communication service.
This pilot study aimed to explore the feasibility and
the potential clinical benefits of a SMI-specific mobile
technology health management tool (‘Florence’) to
enhance community care for people with SMI.
Methods
Study design and participants
This randomised-controlled pilot study used a mixed-
method design to determine the feasibility of conducting
a larger-scale randomised controlled trial (RCT) to
evaluate the potential clinical benefits of using a mobile
technology-assisted community care intervention (as
compared with routine care for people with severe
mental illness). Qualitative and quantitative data
were collected at baseline and six months after the
intervention.
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There were two trial arms:
– Control group: received routine community mental
health care under the Care Programme Approach
(treatment as usual / TAU)
– Intervention group: received enhanced community
care intervention that uses interactive SMS
communication tools in addition to TAU.
Intervention development, study setting, and recruitment
procedure
The mental health specific mobile technology health
management tool (‘Florence’) was developed through a
co-production method (consultation group events) by a
group of clinicians (Florence team members, consultant
psychiatrist and psychologist, care coordinators) and
patient experts by experience; this included the text
messaging protocol, the wording for automated re-
sponses, agreements regarding the frequency for text
message reminders for medication and appointments as
well as putting together a user guide for patients.
The feasibility study was conducted within community
mental health team settings in East London, involving
two Community Mental Health / Recovery Teams and
one Early Intervention in Psychosis team. Following a refer-
ral from clinicians, a research assistant arranged for a meet-
ing to discuss study processes and the mobile technology
intervention in detail, obtained written informed consent
and conducted baseline assessments. Patients allocated to
the intervention arm who did not own a mobile phone
were provided with a mobile phone for the study.
Inclusion criteria
Eligible patients were those 18–65 years old who received
mental health care from one of the community mental
health teams (including Early Intervention in Psychosis
teams) provided by East London NHS Foundation Trust.
Other criteria:
 Established diagnosis of Severe Mental Illness
(Schizophrenia, Schizoaffective Disorder, Bipolar
Disorder)
 Duration of illness ≥ one year
 Currently receiving care within the framework of
the Care Programme Approach (be on CPA and
have a care coordinator assigned to them or receive
secondary mental care service in a depot clinic with
regular reviews)
 Basic command of English
Exclusion criteria
 Lack of capacity (as assessed pre consent giving by
patient’s clinicians)
 Organic psychosis
 Diagnosis of Learning Disability
 Currently an inpatient receiving acute care in
hospital
Intervention
The experimental intervention was an adapted version
of the ‘Florence Simple Telehealth system’ (http://www.
simple.uk.net), specifically designed for community care
of patients with severe and/or enduring mental health
problems. The ‘Florence’ text-messaging system (also re-
ferred to as ‘Flo’) was already available within the organ-
isation (Community Health services in East London) and
was used for supporting people with long-term physical
conditions in the community. The manager of that
service (experience in logistics and data handling) acted
as a technical lead/advisor for the study. The interven-
tion utilises the potential benefits of the ‘Florence’
technology for service user’s treatment adherence and
therapeutic engagement. The research team created in
co-production with service users an innovative mental
health version for self-monitoring of relapse indicators,
and for medication adherence reminders. The technol-
ogy tools were designed to enable service users agreeing
on three individually defined wellbeing indicators for
their daily wellbeing scores, to monitor those in
collaboration with health care professionals and ultim-
ately foster communication between the service user and
clinician outside routine appointments.
A detailed description of the three intervention
elements designed for the study project:
1. Medication/Wellbeing Reminders: ‘Florence’ sent
service users four SMS text messages daily at
individually specific times: two reminders for
medication adherence or appointments and two
asking service users to submit their wellbeing
indicators
2. Wellbeing Indicator: Service users developed a
personalised wellbeing indicator based on three
individually defined issues/relapse signs (e.g. sleep,
anxiety, voice-hearing intensity; see Fig. 1). Each
item is rated as 0–2 (0 = having problems; 1 =minor
problems; 2 = No issues/coping well), and the
service user sends the sum-score of these three
items (0–6, with ‘6’ indicating highest level of well-
being) into the system on a daily basis. Depending
on the scores received, automated response
messages programmed into the ‘Florence’ system
were provided. These included positive feedback
(score 5–6; positive enforcement/encouragement),
advice (score 3–4; how to self-support or access
service support) or prompted service users to
contact their care coordinator to discuss problems
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they experienced (score 0–2). See Table 1 for auto-
response options for the wellbeing score.
3. Request Support Function: At any time, service
users could use ‘Florence’ to send a message
requesting support using a predefined list of help
codes (see Table 1 for auto responses to help
codes). In response, the care coordinator would
contact service users to get more detailed
information regarding the nature of the problem.
The intervention was introduced to the service user by
the care coordinator and the research assistant, in
Fig. 1 Wellbeing Matrix of individualised factors relating to wellbeing. Each item is rated on a 3 point Likert scale. The sum of scores for each
factor determines the wellbeing score submitted to ‘Florence’ in the format “WellX”
Table 1 ‘Florence’ Submission Auto-responses to Wellbeing Scores and Help Codes
Wellbeing Score Automatic response to wellbeing score submission
5 or 6 Thank you. You’re doing really well. Take note of what you’re doing to help yourself. Flo
3 or 4 Thank you. Good to hear you’re coping well. Keep it up, Flo
2 Thank you. Sorry to hear things are difficult for you. You might want to look at your crisis plan to help yourself manage. Flo
0 or 1 Thank you. Sorry to hear you’re not feeling well. You might want to call the crisis line for advice on [local phone number given]
or contact your care coordinator.
Help Code Automatic response to submitted request for help
Mental health
MH
Thanks for letting us know you’re having difficulties with your mental health. You can call the crisis line for advice if you need it:
[local phone number given]
Physical health
PH
Thanks for letting us know you’re having difficulties with your physical health. It may be best to book an appointment with your
GP or attend A&E
Safety SF Thanks for letting us know that you don’t feel safe. You can call the crisis line for advice on [local phone number given] or in an
emergency call 999
Medication MED Thanks for letting us know that you’re having problems with medication. You can call your GP or ask for an appointment with
your psychiatrist to discuss this
Side effects SE Thanks for letting us know that you’re having side effects. You can call your GP or ask for an appointment with your psychiatrist if
you need to discuss this
Social contact SC Thanks for letting us know that you’re having problems with social contact. Someone you trust might support you at this time if
you talk it through with them
Finance FI Thanks for letting us know that you’re having finance problems. You could try asking for advice from community links on [local
phone number given]




Thanks for letting us know that you’re having Asylum problems. You could try calling RAMP for advice on [local phone number]
Employment EP Thanks for letting us know that you’re having employment problems. You could try asking for advice from Workplace on [local
phone number]
Flo Florence Intervention; A&E Accident and Emergency; GP General Practitioner; RAMP Refugee and Migrant Project; Workplace A local service offering
employment advice
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addition, service users received a leaflet explaining the
details of the intervention.
The electronic messaging system enabled online
monitoring of the wellbeing scores on a dashboard (see
example in Fig. 2). If a service user gave a relapse indica-
tor score of 0–1 (i.e. indicating some relapse signs) the
care coordinator was requested to arrange for a
telephone/Skype session or face-to-face contact with the
person. The service user would be contacted within 24 h
(weekday) or on the first day of the week if the message
was submitted on weekend days. Service users were
clearly advised that the ‘Florence’ system would not re-
place the usual acute and crisis care arrangements.
The control condition was Treatment as Usual (TAU),
i.e. standard community mental health care. TAU in-
volved routine follow up with one monthly face-to-face
contact by any mental health care practitioner (usually
the care coordinator) and 3–6 monthly medical reviews
with a psychiatrist.
Outcome measures (all at baseline and six months
after the intervention was completed).
We collected data for baseline characteristics from
electronic patient record systems. Data included socio-
demographic information, diagnoses and ICD codes,
care cluster codes, medication prescribed, number of
previous hospitalisations, date of the last hospitalisation,
duration of illness, and history of relapse due to non-
compliance.
The primary outcome measure was the DIALOG scale
(PROM: patient-reported outcome measure) [21] at
baseline and after six months. DIALOG captures patient
satisfaction scores on domains representing subjective
quality of life measures (SQOL) components of the DIA-
LOG+ intervention [22]. There are eight SQOL domains,
these are mental health, physical health, job situation,
accommodation, friendships, leisure activities, partner/
family, and personal safety. These are rated by the
patient on a Likert scale ranging from 1 (couldn’t be
worse) to 7 (couldn’t be better). Using the same Likert
scale within DIALOG an additional three items measur-
ing treatment satisfaction were scored: medication, prac-
tical help received and meetings with professionals
(PREM: Patient Reported Experience Measure).
Secondary outcome measures were measured at
baseline and after six months:
1. Intervention adherence: Recorded by measuring
SMS response rates on the ‘Florence’ system. This
involved recording daily wellbeing scores as well as
the patient’s text inputs into the system.
2. Treatment adherence: Recorded by assessing
compliance with medication using the Medication
Adherence Rate Scale (MARS) [23, 24]; the scale
consists of 10 items and patients rate the answer as
“Yes” or “No”; The total score ranges from 0 to 10.
with a higher score indicating better adherence.
3. Patient satisfaction with treatment: Recorded using
the Client’s Assessment of Treatment Scale (CAT),
[25]; the scale assesses patients’ subjective
satisfaction and perceptions of their treatment using
7 items (e.g., “do you believe you are receiving the
right treatment/care for you here?”). Each item is
rated on a visual analogue scale with 11 points with
scale endpoints that ranged from 0 (‘not at all’) to
10 (‘yes entirely’).
4. Factors contributing to effective self-management
skills were measured using two validated scales:
a) General Self Efficacy Scale [26]; a self-report
measure of self-efficacy with 10 items, total score is
calculated as the sum of the items and ranges
between 10 and 40, with a higher score indicating
Fig. 2 Example of an auto-plot of self-rated wellbeing scores over time
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more self-efficacy. Measures were reported as mean
scores (range 1–4).
b) Mental Health Confidence Scale [27]; a 16-item
scale for patients to rate their degree of confidence
on a 6-point Likert scale from “1 (very Non
confident) to 6 (Very confident). The total score
ranges from 16 (very low confidence) to 96 (high
level of confidence).
Randomisation
Once written informed consent had been obtained, eli-
gible patients were randomly assigned to TAU or the
intervention in addition to TAU. Random assignment of
group allocation was conducted using concealed con-
secutive numbers (computer-generated), provided by an
independent academic unit staff member not involved
with the trial. Both conditions were delivered in the
community. Masking was not possible due to the nature
of the experimental intervention.
Sample size
Given the exploratory nature of the pilot study, we did
not conduct a sample size calculation but followed the
principles established in the wider literature (flat rules of
thumb for overall pilot trial sample size of a two armed
trial); we decided to aim for a sample of > 50 participants
(> 25 per arm) as recommended for standard effect sizes
that are small to medium [28].
Assessment of the feasibility of the RCT
The following criteria were set before the study started
to indicate that both the study and intervention were
feasible for a full RCT:
1. Recruitment of target sample size within the given
recruitment period of consecutive 12 months, i.e. 5
participants per month
2. Engagement of 80% of participants allocated to the
‘Florence’ intervention.
3. Retention of 60% of participants for the ‘Florence’
intervention.
4. Follow-up data available from 70% of participants
on the primary outcome at six months
Ethics approval and consent to participate
Ethics approval was obtained from the London-Camden
& Kings Cross Research Ethics Committee (Health
Research Authority) Reference: 16/LO/1117, Protocol
number: R-403-668, IRAS project ID: 205395. All
methods were performed in accordance with guidelines
and regulations and all participants provided written in-
formed consent to participate.
Statistical analysis
Descriptive statistics were completed for all of the out-
come data and presented separately for treatment arms at
baseline and follow-up. We conducted t-tests to compare
baseline sociodemographic and clinical baseline character-
istics of the two groups. All analyses were conducted using
IBM SPSS statistics 25 for Windows. The feasibility trial
aimed to evaluate the acceptability and viability of the
health technology intervention in this patient group and it
was not powered to detect significant differences. To
evaluate the relative effects of the two treatment condi-
tions, univariate analyses of covariance (ANCOVAs) for
each of the outcome measures (DIALOG PROM and
PREM, General Self Efficacy sale, Mental Health Self Effi-
cacy Scale and Medication Adherence Scale) were per-
formed, using the pre-treatment scores as covariates.
Pearson’s correlation was used to examine correlations
among wellbeing scores and outcome measures.
Qualitative study
The qualitative part of the study was designed to under-
stand how patients and staff experienced using the inter-
vention and being part of the pilot trial. Information
regarding experiences using the intervention and accept-
ability of the ‘Florence’ system was obtained through in-
dividual semi-structured interviews at follow-up with
patients (N = 31 completed). Interviews were also con-
ducted at baseline with patients in both arms of the trial
(25 in the control and 31 in the intervention arm) to de-
termine how patients experienced care as usual.
The semi-structured interviews took place in the commu-
nity at the team base or patients’ home (according to their
preference); they were conducted using a topic guide and
were recorded (transcribed verbatim) by the two study re-
search assistants. The participants had no prior relationship
with the researchers. The researchers were psychologists by
professional background and trained in conducting inter-
views, and written consent was obtained before the inter-
view began. Additional data were collected from staff (N =
21) via email circulation of a questionnaire which asked
open questions about their experience of ‘Florence’.
Analysis of the qualitative data (by DM and SB) took
place after the quantitative analysis was completed.
Interview recordings were subjected to thematic analysis
[29], coded initially (by DM) using NVivo version 12
qualitative data analysis software. All data were themat-
ically coded by a second experienced qualitative inter-
viewer (SB), and results were discussed by both to
conclude the final thematic analysis.
Results
Participant flow and data
A total of 127 referrals were made for enrolment into
the trial, 102 were eligible for inclusion and invited to a
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further assessment. A portion of participants either did
not attend the baseline assessment (N = 13) or declined
to participate in the trial (N = 24) leaving 65 participants
eligible for allocation, see the Consort study flow dia-
gram (Fig. 3). Patients were recruited from Community
Mental Health Teams/Recovery teams (N = 42) and Early
Intervention in Psychosis teams (N-23). Eligible partici-
pants were recruited over 11 months (August 2016 to
June 2017). The observational period for both arms was
six months from baseline assessment (last follow-up as-
sessments conducted in January 2018). No losses or ex-
clusions at randomisation were recorded. There was
only one protocol deviation, different to the first
protocol version; we also decided to include patients
from an enhanced primary care service associated with
the Community Mental Health teams, provided they ful-
filled all inclusion criteria.
Assessment of the feasibility of the RCT
The study met the four predefined criteria to assess the
feasibility of the RCT. The number of people recruited
exceeded the target sample size of five participants a
month; the rate of recruitment was 5.9 people per
month. For the participants allocated to the Florence
intervention, 89% of the participants engaged with Flor-
ence (80% engagement threshold set) and 56 participants
Fig. 3 Consort Flow Diagram
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(86%) were retained in the study (60% retention thresh-
old set), and for these follow-up data were obtained
(70% follow-up threshold set).
Baseline participant characteristics
The total participant group consisted of 34 female and
31 males with a mean age of 35.2 years. The mean age of
leaving education was 19.9 years. The ethnicity of the
group was broadly in keeping with the expected popula-
tion percentages for the locality in East London: 19.4%
white Caucasian, 17.9% Black African, 16.4% Bangladeshi,
13.4% Pakistani, 10.4% Black Caribbean, 7.5% Indian, and
6% Black other.
Nearly half of participants (46%) were diagnosed with
Schizophrenia (N = 31; ICD10 F20), predominantly para-
noid schizophrenia subtype. Other diagnoses included:
21% bipolar affective disorder (N = 14; F31), 15% psych-
otic disorder unspecified (N = 10, F23), 12% schizoaffec-
tive disorder (N = 8; F25) and 3% delusional disorder
(N = 2; F22).
Sociodemographic and clinical baseline characteristics
of the two groups are included in Table 2. Both groups
were well matched in their baseline characteristics, t-
tests revealed no significant differences between groups.
Utilisation of the intervention elements
None of the participants make use of the Request
Support Function at any moment in time, suggesting
that this element of the intervention was not sufficiently
explained and / or introduced. All patients on medica-
tion received daily two reminders for their oral mainten-
ance medication.
The Wellbeing Score element of the intervention was
utilised by 27 of the 29 participants who received the
intervention; N = 20 patients used the wellbeing moni-
toring consistently every month of the six-month inter-
vention period. The range of wellbeing scores sent into
the Florence monitoring system per month was 5–27
scores, 20 participants sent their score at least on 50% of
days (minimum of 15 per month), the mean number of
wellbeing scores per month was N = 16.6. Eleven partici-
pants continued to use the wellbeing scoring feature for
another 2–6 months after they completed the trial
intervention (total number of wellbeing scores for these
participants ranged from 57 to 327).
Quantitative outcome data analysis
The data analysis did not identify significant changes
over time in favour of the ‘Florence’ intervention arm in
any outcome; clinical outcomes are summarised in
Table 3. Most patients had on average relatively high
baseline scores for primary and secondary outcome
domains (representing relative higher satisfaction with
subjective Quality of Life domains, as well as a higher
level of self-efficacy, self-confidence and medication
adherence).
The statistical analysis revealed that patients mean
wellbeing scores over time were highly positively corre-
lated with all main outcome measures (sum-scores at
follow-up; Pearson’s correlation coefficients of 0.58–0.68).
Results from the Client’s Assessment of Treatment
(CAT) scale indicated high level of satisfaction with
treatment in general, understanding of health profes-
sionals, medication (mean scores in both groups of 7.0–
8.2; s.d. 1.6–3.2; on scale between 0 and 10).
Qualitative interview data (findings from thematic
analysis)
The findings presented here include service user and
staff responses from the interviews. We present data that
gives indication of how Florence may have influenced
care in addition to treatment as usual. Overall, the find-
ings from the qualitative interviews are organised around
three main themes 1) the impact of the ‘Florence’ inter-
vention on routine community mental health care 2) the
acceptability of the Florence intervention amongst ser-
vicer users and community mental health professionals
3) recommendations for future development of the Flor-
ence intervention. The thematic analysis is presented
below, further examples of illustrative quotes for each
theme can be found in Table 4.
Theme 1: the impact of the ‘Florence’ intervention in
community mental health care
Service users in the intervention arm of the trial
highlighted several ways that the clinical care was
Table 2 Baseline characteristics and clinical data of participants who entered the Flo trial
‘Florence’ + TAU TAU t-test
(N = 37) (N = 28) (Df = 62/63)
Gender female, n (%) 19 (51) 15 (54) –
Age, mean years (sd) 36.2 (11.4) 33.9 (10.9) n.s.
Duration of illness, mean years (sd) 16.3 (11.3) 12.1 (9.2) n.s.
Age leaving education mean age (sd) 24.4 (18.7) 28.1 (25.3) n.s.
Number of previous hospitalisations, mean number (sd) 2.6 (2.5) 2.3 (2.6) n.s
n.s. not significant; sd Standard deviation; TAU Treatment as usual
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impacted by the use of the ‘Florence’ intervention, these
included: 1) ‘Florence’ facilitating communication with
clinicians 2) valuing medication reminders, and 3) help-
ing people to focus on feelings.
Florence facilitating service user-clinician communication
Most participants felt that the structure of care they received
did not change as a result of using ‘Florence’, however, a few
service users reported an increase in the number of meet-
ings with their care coordinator and more responsive care
(e.g. a low wellbeing score led to a phone call from a clin-
ician). Some participants spoke about conversations that
had been initiated with their care-coordinator about using
‘Flo/rence’ and agreeing on collaborative working. Frequent
contact with the clinical team or knowledge that they could
contact them if they needed was important for several par-
ticipants. This was recognised as providing comfort and
demonstrating that there was consistent support available
from the healthcare team, emphasis was placed by some on
the specific advice provided by clinicians.
“Probably constant communication, a good care
coordinator who understands me for when I feel like
I’m going off the rails. I can email them, and they
respond well. So, email and understanding from care
coordinator.” [Flo, SU, 021].
Service users also spoke about valuing the quality of
the therapeutic relationship with their healthcare team;
‘they’re a really good team’, the demonstration of
support and understanding was recognised as integral to
the interaction.
The value of ‘Florence’ medication adherence reminders
A large proportion of participants who had trialled the
‘Florence’ intervention had an overwhelmingly positive
experience of receiving medication reminders. A few
participants indicated that the ‘Florence’ system had
helped them to get into the routine of taking medication
and that thereafter they no longer needed the medica-
tion reminders. One clinician commented that a partici-
pant had been able to take more responsibility for their
medication which had enabled them to function more
independently from family members and develop mutu-
ally supportive relationships:
“[Name] has been able to individuate from [their]
mother, by taking more responsibility for [their] own
care, and this in turn has led to their relationship
being more some symbiotic; mutually supportive.”
[Flo, CC, 009].
Another clinician suggested that ‘Florence’ might be a
useful tool for promoting self-management skills in pe-
riods of vulnerability and reduced function, such as on
discharge from inpatient care and may not be necessary
as a long-term intervention.
Table 3 Clinical outcome measures (ANCOVAs, adjusted for baseline score)
‘Florence & TAU’ TAU Difference (95% CI)
N Mean s.d. N Mean s.d.
DIALOG PROM mean score 8 items
- at baseline 30 4.6 0.8 24 4.3 1.4
- post-treatment 30 4.8 1.1 24 4.6 1.2 −0.27 (−0.51 to −0.02) *
DIALOG PREM mean score 3 items
- at baseline 31 5.6 0.9 25 5.1 1.4
- post-treatment 31 5.7 1.0 25 5.3 1.0 −0.14 (−0.49 to 0.20) n.s.
General Self Efficacy Scale (GSE)
- at baseline 30 2.8 0.7 23 2.7 0.8
- post-treatment 30 2.7 0.7 23 2.8 0.6 0.16 (−0.17 to 0.20) n.s.
Mental Health Confidence Scale
- at baseline 29 65.4 15.4 24 61.8 19.5
- post treatment 29 62.4 17.2 24 66.5 15.5 −0.85 (−4.97 to 3.23) n.s.
Medication Adherence Scale (MARS)
- at baseline 31 7.7 2.1 25 7.6 2.7
- post-treatment 31 7.6 2.3 25 7.7 2.1 −0.14 (−0.79 to 0.50) n.s.
DIALOG PROM: Patient Reported Outcome Measures, mean across 8 domains (mental health, physical health, job situation, accommodation, leisure activities,
relationships, friendships, personal safety); DIALOG PREM: Patient Reported Experience Measures, mean across 3 domains (satisfaction with: medication, practical
help, meetings); n.s not significant; TAU Treatment as usual; * The mean difference is significant at the .05 level.
*Each Scale is positively ranked where higher scores indicate higher satisfaction/efficacy/confidence/adherence
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Florence supporting service users and clinicians to
focus on feelings Most participants described an initial
positive experience of reflecting on their daily
functioning by giving a wellbeing score, some found this
more cumbersome over time, leading to reduced fre-
quency or discontinued responses. Many participants felt
Table 4 Themes, sub-themes and illustrative quotes from thematic analysis
Theme 1: The impact of the ‘Florence’ intervention in community mental health care




“Florence worked well, like someone checking in, and
getting the text message back giving advice or saying
you’re doing well was helpful. I was looking forward to
the message, like a friend.” [Flo, SU, 009]
“Perfect intervention to communicate their well-being or
otherwise to their CCO regularly”. [Flo, CC, 007].
1.2: The value of ‘Florence’
medication adherence
reminders
“I just like it cause it’s so helpful. Particularly if you’re
having a bad day as I would forget meds, mainly the
evening ones when feeling low so having the reminders
was helpful.” [Flo, SU, 025].
“Brilliant. A few times where I was busy, it would remind
me to take my medication” [Flo, SU, 025]
“It changed a lot because before, a few times I used to
forget to take the medications but now it prompts me to
take the medications at the right time so there’s no
complications.” [Flo, SU, 050]
“Would be really good for clients when they are coming
out of hospital for at least a week or maybe a month to
help compliance with medication. Especially for people
who have regular admissions after non-compliance. I also
think it would be helpful for GP surgeries when medica-
tions are first prescribed to help for compliance and mon-
itoring”. [Flo, CC, 063]
1.3: Florence supporting
service users and clinicians
to focus on feelings
“It’s very nice that the system also asks how I’m doing
every day on a scale of 0–6 so it makes me think about
how I’m doing all the time. It’s like mindfulness, it helps
me to be aware of how I’m doing and it like helps me to
be mindful” [Flo, SU, 050]
“… she’s been using it and found it very helpful to track
her mood. I’ve been checking in regularly and it’s helped
me to be aware of how she’s doing”. [Flo, CC, 021]
Theme 2: The acceptability of the Florence intervention amongst servicer users and community mental health professionals
Subtheme Quotes from Service Users Quotes from clinicians
2.1: Satisfaction with
Florence
“No, I think it was all good, overall, I don’t have any
complaints. With the ‘Florence’ system I don’t think there’s
anything that could be improved, I think it’s perfect.” [Flo,
SU, 062]
“Makes you feel less isolated and that you’re being
monitored when not feeling well […] I feel well
supported by the team and [NHS] Trust but not my
family. The Trust could use FLO to help with support and
guidance which would be useful. “[Flo, SU, 009].
“Positive she was happy” [Flo, CC, 47]
2.2: Usability of Florence “The questions were good, straight forward, you just reply
with the number that you’re feeling. It was very easy to
use” [Flo, SU, 050]
“I liked the graph which I think was helpful for Y and she
showed it to me sometimes too. The replies of the
messages was always positive and I appreciated them
most days, they made me smile.” [Flo, SU, 021]
“… 10 people with the same diagnosis as me will have 10
different ways of experiencing the illness. So I like that it’s
specific to me, it makes me feel more in control. I like that
you can change it to your specific needs.” [Flo, SU, 063]
“Flagging up when a service user is not doing well is
helpful” [Flo, CC, 025]
Theme 3: Recommendations for the development of the Florence intervention
Subtheme Quotes from Service Users Quotes from clinicians
3.1: Personalisation of
Florence
“… 10 people with the same diagnosis as me will have 10
different ways of experiencing the illness. So I like that it’s
specific to me, it makes me feel more in control. I like that
you can change it to your specific needs.” [Flo, SU, 063]
“It would be good to be able to adjust the frequency so
by continuing on the same score until I submit a different
score.” [Flo, SU, 031]]
‘Individualising of text messages for each patient,




“A prompt for clinicians to discuss the intervention with
patients would be helpful.” [Flo, Con, 007]
SU Service user; CC Care coordinator; Flo ‘Florence’ intervention; TAU Treatment as usual
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that it was helpful to be asked how they are on a daily
basis and be prompted to reflect on their wellbeing. The
ability to monitor progress using graphs alongside re-
ceiving positive messages on a regular basis was valued,
encouraging empowerment and addressing power imbal-
ances between service users and clinicians:
“The message, well 3, “thank you, I’m glad you’re
coping well is very nice”. It’s tailored to your needs.”
[Flo, SU, 028].
A clinician commented on how it’s helped a service user
to keep track of mood and increased her awareness of
their well-being. Another clinician commented on the im-
pact of the well-being aspect of ‘Florence’ on recovery:
“It also helped them to think about how they were
doing from day-to-day in themselves which in turn
helped them further develop their reflective capacity
and therefore recovery.” [Flo, CC, 009].
Some participants found the scoring a little challen-
ging and acknowledged that sometimes they censored
their responses and at other times avoided contact with
their care coordinator. Some felt cautious about being
monitored ‘they never used to check up on me before,”
whilst others acknowledged this could be a useful gate-
way to accessing care and averting crises.
Theme 2: the acceptability of the Florence intervention
amongst servicer users and community mental health
professionals
Satisfaction with Florence Service users and staff were
broadly satisfied with the utility of the text messaging
tool, 27 out of 42 staff (64%) thought that ‘Florence’
would be a useful service for their clients and generally,
clinicians thought that some service users would be open
to using this digital technology:
“yes, people expressed they would like to be asked
about their mood and perhaps use the ‘Florence’
similarly to a mood diary. It seems useful for people
who are actively looking to engage with their mental
health.” [TAU, CC, 066].
Service user participants were asked if they would con-
tinue using the system, 16 people (64%) said they would
continue using the ‘Florence’ system. Several people
expressed that that system was ‘excellent’, and one
participant thought it should be ‘scaled up’:
“They should use this on a larger scale, more
frequency of texts.” [Flo, SU, 009].
Some participants expressed retrospectively how they
were pleasantly surprised by the impact of this interven-
tion and that they were still using it. Some were
surprised to see a quick response from their clinician
when a low score was recorded:
“The first time I got a call from [name of care-
coordinator] when I scored really low and she called
me I was quite surprised because I didn’t know that
they got the feedback.” [Flo, SU, 046].
Similar to service user perspectives, one clinician also
discussed the helpfulness of the alert when well-being
scores were very low, supporting access to care and pre-
venting crisis:
“Flagging up when a service user is not doing well is
helpful in Flo” [CC, 025].
Other clinicians highlighted it could be useful in help-
ing service users to develop self-management skills, that
medication reminders were well received, that it was
simple to use, and that it could act as a conduit between
the service user and the care coordinator.
Usability of Florence Some service users reported that
they were hesitant about using the ‘Florence’ system at
first and were uncertain about its utility, however, ac-
knowledged that they adjusted to the system and felt it
was ‘fairly straight forward’ with easy to read and clear
questions. One person said that they did not use all the
functions of ‘Florence’ such as the help codes and ques-
tioned their understanding of using the system. Some of
the respondents who wanted to continue using the system
offered ways they would like to tailor the use whilst a few
participants spoke about technical challenges experienced
(e.g. scores not being received by the care-coordinator).
Theme 3: recommendations for the development of the
Florence intervention
Service user participants made recommendations about
how the ‘Florence’ system could be adapted for future
use in the services.
Personalisation of Florence Personalisation of the sys-
tem based on the service user’s individual need and their
daily routines was important to many of the participants.
Some people felt that the frequency and timing of com-
pleting wellbeing scores could be adapted to be less or
more frequent depending on individual need. The time
that they received wellbeing score reminders was not al-
ways suitable for many respondents:
Röhricht et al. BMC Psychiatry          (2021) 21:357 Page 11 of 16
‘10 in the morning it’s too early and some people’s
days haven’t started’.
Another participant suggested alternative formats for
the wellbeing scores such as using an emoji, whilst an-
other wanted to reply with more detail and put how they
were feeling in words rather than using a score:
“It would be good to be able to text back something
else, like words. I know there were a list of words
that I could have text back, but I really want to text
back what I’m feeling. [ …] Every number I know
corresponds to how I was feeling. 6 was I’m on top of
the world and 0 meant I’m going to go and jump off
a bridge, but what does 3 mean …? ” [Flo, SU, 063].
Some expressed that they would like more flexibility
or control of the functions, such as be able to submit
well-being scores after 10.30 pm or the ability to tailor
the timing of reminders.
Practical considerations of implementing ‘Florence’
Some members of staff provided recommendations for
the usefulness of ‘Florence’ whilst others expressed spe-
cific use for ‘Florence’, such as when supporting service
users to make transitions, or for use in an outreach for-
mat rather than offered as part of routine care. One staff
member expressed concerns about the automated nature
of the system:
“Service users to have more responsibility and power
on sharing their information with clinicians,
therefore no automatic response, but a choice of
whether to share the last weeks or days score with
care coordinator. This may increase service user
autonomy.” [Flo, CC 25].
One clinician felt that more guidance and a prompt to
remind them to discuss ‘Florence’ with their service
users should be considered. Whilst others described
contextual barriers they experienced whilst implement-
ing Florence, such as the perceived increase in team
workload alongside the consideration of other digital
technology being trialled within the care offer.
Discussion
To our knowledge, this is the first randomised-
controlled trial to investigate the clinical utilities of a
‘Simple-Telehealth’ (Florence) text-messaging technol-
ogy to assist the mental health care of patients with
severe and enduring mental illness. Preliminary evidence
from small cohort and case studies suggests that
“Florence is a low-cost, low-risk innovation with a strong
track record” [30]; studies reported benefits on self-
management, recovery outcomes and treatment adher-
ence, predominantly in the management of physical
long-term conditions such as hypertension and diabetes
[31], but also more recently for patients with mental
health problems following psychotherapy [32]. Other
studies provided preliminary evidence for the effective-
ness of more complex text-messaging interventions that
incorporated Cognitive Behaviour Therapy techniques to
target medication adherence and psychotic symptoms
[33] or used an ‘Early Warning Signs Questionnaire’ for
relapse prevention [34].
Study findings
The overall aim of this randomised controlled pilot
study was to explore the feasibility and the potential
clinical benefits of the ‘Florence’ mobile health manage-
ment tool for people with SMI.
Trial findings demonstrate that it is feasible to imple-
ment the intervention within this patient cohort and that
the study design can be delivered. All four pre-set cri-
teria to assess feasibility were met; attrition rates were
acceptable and within normal limits, and the study dem-
onstrated subjective benefits (clinical significance) by fa-
cilitating recovery-oriented community mental health
care for patients with severe and enduring mental illness.
No harmful effects were observed as a result of the trial.
Those who were in the TAU arm showed enthusiasm to
use the intervention as well.
Qualitative data collected from staff also showed that
there was a lot of interest in supporting the implementa-
tion of the project by clinicians; however, some staff did
raise resource concerns. An enabler of the pilot trial was
the support received by sponsors in promoting the re-
search within the clinical teams where the study took
place. Support provided by the Telehealth team was piv-
otal, escalating messages to the care coordinators as re-
quired and also concerning teams’ decision making to
continue using ‘Florence’ beyond the research project.
One feature of the intervention was not utilised as per
protocol; this was the interactive messaging option con-
cerning unmet needs (help codes). Follow-up interviews
revealed that a significant contextual challenge impacted
upon the delivery of this aspect of the intervention: fol-
lowing a service redesign, local teams had undergone re-
location and merger from four separate teams to two
teams only three months before the recruitment phase.
Although it is difficult to quantify the impact that this
had on engagement and recruitment, it is likely to have
influenced staff morale and motivation to improve
client-practitioner communications, as there was con-
cern that this may increase the workload further. A fu-
ture trial needs to strengthen the health professional
involvement for the delivery of this element (e.g. revised
set-up procedures and training package).
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Results for the primary subjective quality of life out-
come measure (DIALOG) significantly increased from
baseline to follow-up, but the study did not detect sig-
nificant differences between the experimental and TAU
groups for the primary or secondary recovery outcome
measures over time; this has been associated with the
fact that baseline scores for all outcomes were relatively
high and therefore indicating that a more stable cohort
with lower levels of dissatisfaction was recruited to
participate. This ceiling effect in the participant’s subject-
ive quality of life, self-efficacy/−confidence and treatment
adherence levels left little room for further improvement.
The participants however had been in need for service
support for many years (average duration of illness 16
years) and indicated some significant benefits using the
telehealth intervention, particularly self-monitoring of
wellbeing and medication reminders. It is possible that
more noticeable changes in the outcome measures may be
found in participants in different stages of recovery;
patients who have just accessed mental health services in
crisis such as those experiencing first-episode psychosis or
a psychotic relapse/breakdown or profound chronic symp-
toms are likely to have lower baseline scores.
Patients valued the (twice daily) medication reminders,
reporting that this would be particularly helpful if they
had a difficult day, thereby suggesting that the reasons
for non-adherence were predominantly unintentional
and not a result of negative attitudes towards mainten-
ance therapy. The medication reminders helped to
develop a daily routine for some participants. Similarly, a
recent systematic review found that patients with unin-
tentional non-adherence may benefit from automated
text messages or app reminders [35].
Participants reported that the tool could enhance the
therapeutic relationship and maintain continuity in care.
This is a topic that requires further exploration in re-
search, given the ongoing debate [36] about the impact
of telemedicine on the therapeutic alliance within differ-
ent patient populations and taking into account the
varying therapeutic objectives.
The fact that the wellbeing scores were highly corre-
lated with recovery care outcome measures suggests that
a relatively simple and individually defined wellbeing
score is highly predictive of a range of outcomes relevant
for the provision of recovery care services for severely
mentally ill patients and could be usefully easily imple-
mented into routine care. Wykes & Brown [37] con-
ducted a risk-benefit analysis of e-health tools and
interventions, emphasising the importance of skilled
responses from clinicians to self-monitoring data. The
approach chosen for the self-monitoring of wellbeing in
this study with a self-defined score based upon three
most relevant relapse indicators has significant advan-
tages; the resulting (positively coded) wellbeing scores
reliably identified those patients who require more
immediate support (scores of 0–1). This allows the allo-
cation of limited resources in a more clinically informed
and cost-effective manner. Some patients found the
request for a wellbeing score helpful for making them
more aware of their wellbeing and for identifying re-
lapse. The clinicians also reported that ‘Florence’ could
help patients to develop reflective capacity. This is
different to tools evaluated in other studies, where an
automated telehealth device (e.g. ‘Health Buddy’ or
‘MONARCA’ system) operates on the basis of a
predefined content library to determine symptoms for
self-monitoring [38, 39].
The main recommendation from patients was that the
intervention could be customised to meet individual
preferences, some study participants reported that they
became either quickly fatigued by the frequency of mes-
sages or felt that they were too intrusive. Similar reports
have been raised in the literature [35]. A desire to have
more autonomy over the use of the ‘Florence’ tools was
also emphasised by one of the staff participants. Em-
powerment is one of the key aspects of recovery-focused
care and therefore, should feature in technology-assisted
self-management tools aimed at supporting recovery and
enable patients to exercise more choice and control [36].
The option to customise the intervention would ensure
that the intervention was more personalised and maybe
more easily implemented using text-messaging or an
app. Equally, Basit et al. [35; p. 35] recommended to ex-
plore patients’ preferences for the type of technology
tool used for medication reminders and to “focus on pa-
tients with known adherence problems and stratify them
based on the reason for non-adherence (e.g., intentional
and unintentional)”.
Staff raised concerns about the workload implications to
support the implementation of ‘Florence’. Similar con-
cerns have been raised in other studies using telemedicine,
and they are highly dependent on the level of intensity/
interaction of the intervention [35–39]. ‘Florence’ is an
intervention which mainly uses automated text messaging
but also includes a monitoring and follow-up element via
telephone if relapse indicators are evident. Telemedicine
interventions have been previously categorised into levels
of intensity. Interventions solely using automated text
messaging have been classified as low-intensity interven-
tions; however, when automated text messaging is paired
with tele-monitoring and response to alerts the interven-
tion is considered a medium intensity intervention [35].
A potential barrier for the adoption of telehealth inter-
ventions in this population is the ‘digital divide’, i.e. dis-
advantaged populations who do not have access and use
of digital media; previous studies reported that access to
mobile technology is significantly lower than within the
general population [40]. The two challenges with
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implementing telehealth solutions in this population are
skills and access [37]. The provision of a mobile phone
for the participants in this study was a solution aimed at
overcoming the problem of physical access, the potential
further barrier around skills acquisition may require
more attention for people to engage fully with the phone
functions. ‘Florence’ Simple-Telehealth tools however
appeared to have been easily adopted by the majority of
participants in this study, patients reported that the
intervention was easy to use.
For the purpose of this study a simple text messaging
technology was chosen with a view to maximise chances
for patient inclusion. A text-message-only system offers
the lowest threshold for access to the service but limits
the sophistication and personalisation. In future, an app-
based version of the intervention could be tested with
enhanced interactive features, using a stepped-care ap-
proach as suggested by Basit et al. [35].
Strengths and limitations
A strength of the study was that there was a sizeable
qualitative component to this pilot study, with interviews
with patients and clinicians which enable experiences
and suggestions for future recommendations of using
Florence to be captured. In addition, this adapted
version of ‘Florence’ was developed co-produced with
patients to ensure that the automated responses were
relevant to people who received care. Pre-set criteria
were also used to assess the feasibility of the study; this
was complemented by the qualitative data.
A relevant limitation of the study was that people in-
volved in the trial had been in contact with mental
health services for several years and presented in a more
stable stage of recovery at baseline, resulting in a ceiling
effect on the outcome measures. Our data, therefore,
does not indicate how someone relatively new to services
and patients with severe clinical symptoms and or prob-
lems with health/social care engagement would experi-
ence this intervention and how this would support their
recovery. Equally, the intervention might be best suited
for patients who receive crisis care and subsequent pe-
riods of rehabilitation in the community.
Conclusion
In conclusion, recruitment to the trial was feasible, and a
full trial could go ahead. In follow-up trials the inclusion
criteria should be amended and include patients with
higher level of need (lower baseline scores for PROMs, Re-
covery indices and Medication Adherence) and clinicians
should receive a tailor made, dedicated and more in-depth
induction to the intervention tools and receive assistance
in managing the tools. Patients indicated that they would
want to further personalise the intervention and a full trial
is required to examine potential longer-term benefits as
well as adverse effects associated with the intervention in
a larger sample size. Clinically, the main utility of this
intervention is the user-defined measure of wellbeing to
support patient’s capabilities for self-monitoring and to
foster their empowerment, secondly the medication
reminders as an aiding tool for treatment adherence and
potentially the opportunity for meaningful feedback about
experienced care needs.
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